What is EdenRx and what does it offer?

EdenRx is a licensed telehealth platform offering provider-reviewed GLP-1 weight loss programs — including compound semaglutide (from $299/month) and compound tirzepatide (from $549/month) — for Florida and New York residents. No clinic visits required. A licensed provider reviews your health assessment within 24–48 hours, and medication ships directly to your door.

What are GLP-1 medications and how do they work?

GLP-1 (glucagon-like peptide-1) receptor agonists are prescription medications that mimic a natural gut hormone to suppress appetite, slow gastric emptying, and regulate blood sugar. Semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound®) are the most clinically proven GLP-1 medications, producing 15–22% average body weight loss in clinical trials.

How much does semaglutide cost in Florida?

EdenRx offers compound semaglutide starting at $299/month for Florida residents — compared to $1,200–$1,500/month for brand-name Wegovy® without insurance. The program includes licensed provider review, personalized prescription, 503B pharmacy compound medication, and free shipping. No insurance required. Only pay if approved.

How much does tirzepatide cost in New York?

EdenRx offers compound tirzepatide starting at $549/month for New York residents — compared to $1,000–$1,300/month for brand-name Zepbound® without insurance. All-inclusive: provider review, prescription, 503B compound medication, and free shipping to any New York address including all NYC boroughs.

Do I need to visit a clinic for GLP-1 treatment?

No. EdenRx is 100% online. Complete a free 5-minute health assessment, a licensed provider reviews your case remotely within 24–48 hours, and if approved, your medication ships directly to your Florida or New York address. No in-person visits or appointments required.

How much weight can I lose with semaglutide or tirzepatide?

Clinical trial data: semaglutide produces an average of 14.9% body weight loss over 68 weeks (STEP-1 trial, NEJM 2021). Tirzepatide produces up to 20.9% average body weight loss over 72 weeks (SURMOUNT-1 trial, NEJM 2022). For a 200-lb patient: ~30 lbs (semaglutide) to ~42 lbs (tirzepatide). Individual results vary.

What is compound semaglutide vs Ozempic or Wegovy?

Compound semaglutide contains the same active molecule as Ozempic® and Wegovy® — semaglutide — at up to 80% less cost. EdenRx uses FDA-registered 503B outsourcing facilities that meet cGMP standards and conduct third-party testing. Compound semaglutide: from $299/month vs. Wegovy® at $1,200–$1,500/month.

Who qualifies for GLP-1 weight loss treatment?

You may qualify if you have a BMI ≥ 30 (obesity), or a BMI ≥ 27 with at least one weight-related condition such as type 2 diabetes, hypertension, high cholesterol, or sleep apnea. Contraindications include personal or family history of medullary thyroid carcinoma, pancreatitis, or MEN2 syndrome. Complete EdenRx's free assessment to find out if you qualify.

Is EdenRx available in New York City?

Yes. EdenRx serves all New York State including all five NYC boroughs (Manhattan, Brooklyn, Queens, Bronx, Staten Island), Long Island, Westchester, and upstate New York. Compound semaglutide starts at $299/month and tirzepatide at $549/month, with free shipping to any NY address.

What is the best Ozempic or Wegovy alternative?

Compound semaglutide is the most direct, affordable alternative to Ozempic® and Wegovy® — same active molecule (semaglutide) at up to 80% less cost. EdenRx offers compound semaglutide from $299/month vs. $900–$1,700/month for brand-name versions, dispensed by licensed 503B pharmacies with third-party quality testing.

What is a tirzepatide weight loss program?

A tirzepatide program uses weekly injections of compound tirzepatide — a compounded option that is not FDA-approved and is distinct from FDA-approved Mounjaro® — under licensed provider supervision to produce superior weight loss through dual GLP-1 and GIP receptor activation.

Is tirzepatide better than semaglutide for weight loss?

Head-to-head, tirzepatide produces greater average weight loss — up to 22.5% vs 15–17% for semaglutide. However, the best option depends on your individual health profile and provider recommendation.

How much does tirzepatide cost at EdenRx?

EdenRx offers compound tirzepatide at transparent monthly pricing — a fraction of brand-name Mounjaro® costs. Only pay after provider approval. View full pricing at /pricing.

How quickly does tirzepatide work?

Most patients notice appetite reduction within the first 1–2 weeks. Meaningful weight loss typically begins by weeks 4–8.

What is the tirzepatide dosing schedule?

Programs begin at 2.5mg weekly for 4 weeks, then increase through 5mg, 7.5mg, 10mg, and potentially 12.5mg or 15mg based on tolerance and response.

Who qualifies for tirzepatide?

Adults with BMI 30+, or BMI 27+ with a weight-related condition, may qualify. Contraindications include personal or family history of MEN2 or medullary thyroid carcinoma. Your provider will evaluate your full history.

What are tirzepatide side effects?

Most common: nausea, reduced appetite, GI discomfort — especially during dose escalation. These typically improve over time. Your provider monitors your progress.

Can I switch from semaglutide to tirzepatide?

Yes. EdenRx providers can transition patients between GLP-1 medications based on response and clinical assessment.

Tirzepatide Weight Loss Program

Tirzepatide Program — Up to 22.5% Body Weight Loss, Provider-Reviewed

EdenRx's tirzepatide program uses compound tirzepatide — the a compounded option that is not FDA-approved and is distinct from FDA-approved Mounjaro® — the most powerful GLP-1 weight loss medication available. 60-second assessment. Ships to FL and NY.

✅ Provider Reviewed🔒 HIPAA Secure💊 Licensed Pharmacies📦 Delivered to Your Door

Start Free Assessment Explore Wellness Programs

No payment required · Provider-reviewed · Only pay if approved

HIPAA Secure Intake Provider-Reviewed 6,000+ Patients Served Decision Within 24h Licensed Pharmacies Delivered to Your Door

Why Tirzepatide Produces Superior Weight Loss

Unlike semaglutide (which activates only the GLP-1 receptor), tirzepatide activates both GLP-1 and GIP receptors simultaneously. This dual mechanism produces stronger appetite suppression, greater fat burning, and superior metabolic improvements — resulting in up to 22.5% body weight reduction in the SURMOUNT-1 clinical trial.

EdenRx provides compound tirzepatide with licensed provider oversight — the same clinical experience as brand-name programs at a fraction of the cost.

Start Free Assessment